N末端B型利钠肽前体与肌钙蛋白I比值用于鉴别急性冠脉综合征
该回顾性观察研究连续纳入急诊就诊、年龄≥16岁、初始肌钙蛋白I≥0.2 ng/mL的内科患者,排除ST段抬高型心肌梗死或充血性心力衰竭者。共纳入1441例,分为急性冠脉综合征组603例和非急性冠脉综合征组838例。非急性冠脉综合征组的NT-proBNP/TnI比值显著高于急性冠脉综合征组,该比值的AUC为0.805(95%CI 0.784-0.826),显著优于NT-proBNP/肌酸激酶-MB、肌钙蛋白I和NT-proBNP。非急性冠脉综合征组中肌钙蛋白I和BNP均高的患者就诊时病情更危重且死亡率更高。作者认为NT-proBNP/TnI比值可能有助于鉴别急诊肌钙蛋白I升高的内科患者其升高是否由急性冠脉综合征所致。
要点
- 研究对象为急诊就诊、年龄≥16岁、初始肌钙蛋白I≥0.2 ng/mL的内科患者,排除ST段抬高型心肌梗死或充血性心力衰竭者。
- 非急性冠脉综合征组838例的NT-proBNP/TnI比值显著高于急性冠脉综合征组603例。
- NT-proBNP/TnI的AUC为0.805(95%CI 0.784-0.826),显著优于NT-proBNP/肌酸激酶-MB、肌钙蛋白I和NT-proBNP。
- 非急性冠脉综合征组中肌钙蛋白I和BNP均高的患者就诊时病情更危重且死亡率更高。
适用人群与场景
- 急诊就诊、年龄≥16岁、以内科疾病入院、初始评估时肌钙蛋白I≥0.2 ng/mL的患者。
- 排除诊断为ST段抬高型心肌梗死或充血性心力衰竭的患者。
诊断标准与关键阈值
- 纳入标准:年龄≥16岁;经急诊以内科疾病入院;急诊初始评估肌钙蛋白I≥0.2 ng/mL。
- 排除标准:诊断为ST段抬高型心肌梗死或充血性心力衰竭。
红旗征与不能漏的情况
- 非急性冠脉综合征组中肌钙蛋白I和BNP均高的患者就诊时病情更危重且死亡率更高。
研究设计与关键结果
- 研究类型为回顾性观察研究,连续纳入急诊患者,共1441例,其中急性冠脉综合征组603例、非急性冠脉综合征组838例。
- 非急性冠脉综合征组的NT-proBNP/TnI比值显著高于急性冠脉综合征组。
- NT-proBNP/TnI的AUC为0.805(95%CI 0.784-0.826),显著优于NT-proBNP/肌酸激酶-MB、肌钙蛋白I和NT-proBNP。
- 非急性冠脉综合征组中肌钙蛋白I和BNP均高的患者就诊时病情更危重且死亡率更高。
证据类型、等级与局限
- 证据类型:回顾性观察研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为NT-proBNP/TnI比值可能有助于鉴别急诊肌钙蛋白I升高的内科患者其升高是否由急性冠脉综合征所致。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: It is difficult to differentiate whether coronary or non-coronary causes in patients with elevated troponin I (TnI) in emergency department (ED). The aim of this study was to develop a clinical decision tool for differentiating a coronary cause in the patients with elevated TnI.
METHODS: This was a retrospective observational study that enrolled consecutive ED patients. Patients were included in the study if they were ≥16 years of age, had admitted through ED with a medical illness, and TnI levels at initial evaluation in the ED were ≥0.2 ng/mL. Patients diagnosed with ST elevation myocardial infarction or congestive heart failure were excluded. Coronary angiography, electrocardiogram, laboratory results, echocardiography, and clinical characteristics were analyzed.
RESULTS: Among the included 1441 patients, 603 and 838 patients were categorized into an acute coronary syndrome (ACS) group and non-acute coronary syndrome (non-ACS) group, respectively. The ratio of N-terminal pro-Btype natriuretic peptide (NT-proBNP) to TnI was significantly higher in the non-ACS group compared to the ACS group. The AUC of NT-proBNP/TnI (0.805, 95% CI, 0.784-0.826) was significantly superior to that of NT-proBNP/creatinine kinase-MB, TnI, and NT-proBNP. The patients of the non-ACS group with high levels of TnI and BNP showed more critically ill manifestation at the time of presentation and higher mortality.
CONCLUSION: NT-proBNP/TnI may help to distinguish medical patients with elevated TnI whether the elevated TnIs were caused from ACSs or from conditions other than ACS.
参考来源
- Kim DH, Lee SH, Kim SC, et al. The ratio of N-terminal pro-B-type natriuretic peptide to troponin I for differentiating acute coronary syndrome. Am J Emerg Med. 2018. PMID: 30122508. doi:10.1016/j.ajem.2018.08.035
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。